V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300003842 | 300002687 | 1.81 | 77 | Adjuvant (A) | null | 2016-01-27 | Trial Unspecified | N | N | 300017073 | TRIAL |
| 300003843 | 300006011 | 1.84 | 91 | null | 2017-04-10 | 2017-04-10 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300017075 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003844 | 300002688 | 1.75 | 56.2 | Curative (C) | 2015-11-12 | 2015-11-18 | CETUXIMAB | N | Y | 300017078 | CETUXIMAB |
| 300003845 | 300002689 | 1.62 | 107.3 | Neo-adjuvant (N) | 2017-04-19 | 2017-04-29 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300017079 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003846 | 300002690 | null | null | Adjuvant (A) | 2017-01-10 | 2017-01-18 | Cetuximab + Radiotherapy Load | N | Y | 300017080 | CETUXIMAB + RT |
| 300003847 | 300006012 | 1.6 | 56 | Palliative (P) | 2017-10-30 | 2017-11-05 | Cisplatin +Fluorouracil (3 wk) | N | N | 300017081 | CISPLATIN + FLUOROURACIL |
| 300003848 | 300002691 | 1.59 | 109.8 | null | 2017-01-01 | 2017-01-02 | Cisplatin +Fluorouracil (3 wk) | N | null | 300017093 | CISPLATIN + FLUOROURACIL |
| 300003849 | 300002691 | 1.62 | null | null | 2015-02-20 | 2015-03-17 | Capecitabine | N | N | 300017093 | CAPECITABINE |
| 300003850 | 300002692 | null | null | null | 2017-02-28 | 2017-03-06 | CETUXIMAB + RT | N | Y | 300017097 | CETUXIMAB + RT |
| 300003851 | 300002693 | 1.73 | 101.5 | Neo-adjuvant (N) | 2013-01-16 | 2013-01-29 | CISPLATIN + FLUOROURACIL | 02 | N | 300017099 | CISPLATIN + FLUOROURACIL |
| 300003852 | 300002693 | 1.77 | 82.2 | Neo-adjuvant (N) | 2014-09-18 | 2014-09-23 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300017099 | CISPLATIN + FLUOROURACIL |
| 300003853 | 300007426 | null | 67.7 | Curative (C) | 2013-11-14 | 2013-11-24 | Cetuximab + Radiotherapy Maint | 2 | Y | 300017103 | CETUXIMAB + RT |
| 300003854 | 300007426 | 1.72 | 87 | Neo-adjuvant (N) | 2017-04-16 | 2017-04-16 | Cisplatin + Docetaxel +Fluorouracil | N | null | 300017103 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003855 | 300002694 | 1.59 | 42 | Palliative (P) | 2014-07-13 | 2014-08-02 | Trial Unspecified | 02 | null | 300017108 | TRIAL |
| 300003856 | 300006015 | 1.57 | 99 | null | 2014-10-05 | 2014-10-06 | CETUXIMAB + RT | Y | null | 300017109 | CETUXIMAB + RT |
| 300003857 | 300007427 | 1.8 | 113.7 | Neo-adjuvant (N) | 2014-10-21 | 2014-10-31 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300017110 | CISPLATIN + FLUOROURACIL |
| 300003858 | 300007427 | 1.69 | 82.1 | Curative (C) | 2015-05-01 | 2015-11-19 | CISPLATIN + FLUOROURACIL | null | null | 300017110 | CISPLATIN + FLUOROURACIL |
| 300003859 | 300002695 | null | 70.8 | Curative (C) | null | 2017-08-04 | Trial Unspecified | null | null | 300017117 | TRIAL |
| 300003860 | 300002695 | 1.75 | 76.5 | Neo-adjuvant (N) | 2015-08-31 | 2015-08-31 | Cisplatin +Fluorouracil (3 wk) | 02 | null | 300017117 | CISPLATIN + FLUOROURACIL |
| 300003861 | 300002696 | 1.6 | 48.1 | Palliative (P) | 2017-04-28 | 2017-04-28 | CARBOPLATIN + PACLITAXEL | Y | N | 300017132 | CARBOPLATIN + PACLITAXEL |
| 300003862 | 300002697 | 1.59 | 57.8 | Curative (C) | 2013-10-11 | 2013-10-11 | Cetuximab + Radiotherapy Maint | N | N | 300017142 | CETUXIMAB + RT |
| 300003863 | 300002697 | 1.67 | 73.6 | Neo-adjuvant (N) | 2016-08-19 | 2016-08-19 | CISPLATIN + FLUOROURACIL | 02 | N | 300017142 | CISPLATIN + FLUOROURACIL |
| 300003864 | 300002698 | 1.73 | 59.6 | Neo-adjuvant (N) | null | 2014-07-17 | Cisplatin +Fluorouracil (3 wk) | N | N | 300017149 | CISPLATIN + FLUOROURACIL |
| 300003865 | 300002699 | 1.6 | 82.1 | Curative (C) | 2017-02-02 | 2017-02-03 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 300017151 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003866 | 300002700 | 1.69 | 86.6 | Curative (C) | 2018-02-13 | 2018-02-26 | CETUXIMAB | 02 | Y | 300017155 | CETUXIMAB |
| 300003867 | 300002701 | 1.72 | 86.6 | Curative (C) | 2014-05-19 | 2014-05-23 | Trial Unspecified | N | N | 300017160 | TRIAL |
| 300003868 | 300006018 | 1.65 | 102 | Adjuvant (A) | 2017-06-10 | 2017-06-20 | Capecitabine | N | N | 300017162 | CAPECITABINE |
| 300003869 | 300002702 | 1.63 | 74.4 | Palliative (P) | null | 2014-03-10 | BILCAP TRIAL | N | null | 300017164 | TRIAL |
| 300003870 | 300002703 | 1.57 | 78.6 | Curative (C) | 2013-09-10 | 2013-09-12 | Cetuximab 7 day (Cycle 1) | N | N | 300017173 | CETUXIMAB |
| 300003871 | 300002703 | 1.8 | 85 | Adjuvant (A) | 2016-09-09 | 2016-09-12 | Capecitabine | 2 | N | 300017173 | CAPECITABINE |
| 300003872 | 300002704 | 1.68 | 96.8 | Neo-adjuvant (N) | 2014-08-13 | 2014-09-01 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 300017179 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003873 | 300002705 | 1.67 | 64.9 | Curative (C) | null | 2015-05-25 | Cetuximab + Radiotherapy Load | N | N | 300017183 | CETUXIMAB + RT |
| 300003874 | 300002706 | 1.68 | 74.2 | Disease modification (D) | 2015-11-30 | 2015-12-15 | CISPLATIN + FLUOROURACIL | 02 | null | 300017184 | CISPLATIN + FLUOROURACIL |
| 300003875 | 300002707 | null | 83.2 | Curative (C) | 2016-09-04 | 2016-09-18 | Cisplatin + Docetaxel +Fluorouracil | N | null | 300017185 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003876 | 300002708 | null | 78.6 | Neo-adjuvant (N) | 2017-04-02 | 2017-04-02 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300017187 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003878 | 300002709 | 1.75 | 67.3 | Adjuvant (A) | null | 2015-02-09 | Capecitabine | N | N | 300017193 | CAPECITABINE |
| 300003879 | 300002710 | 1.59 | 65 | Curative (C) | 2015-12-11 | 2015-12-19 | Cetuximab + Radiotherapy Load | N | Y | 300017194 | CETUXIMAB + RT |
| 300003880 | 300002711 | 1.72 | 70 | Neo-adjuvant (N) | 2015-09-19 | 2015-09-19 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 300017195 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003881 | 300002712 | 1.75 | 49.1 | null | 2014-03-25 | 2014-04-09 | Cetuximab 7 day (>Cycle 2) | N | N | 300017203 | CETUXIMAB |
| 300003882 | 300002713 | 1.5 | 85.8 | null | 2013-08-06 | 2013-09-04 | Cetuximab + Radiotherapy Load | 2 | N | 300017204 | CETUXIMAB + RT |
| 300003883 | 300002714 | 1.62 | 73.3 | Curative (C) | 2015-10-26 | 2015-10-30 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 300017207 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003884 | 300002715 | 1.57 | null | Palliative (P) | 2016-06-21 | 2016-06-30 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300017208 | CISPLATIN + FLUOROURACIL |
| 300003886 | 300002717 | 1.73 | 72.6 | Curative (C) | 2017-10-19 | 2017-10-26 | Cetuximab + Radiotherapy Maint | N | Y | 300017219 | CETUXIMAB + RT |
| 300003887 | 300002718 | 1.92 | 63.3 | Neo-adjuvant (N) | 2016-08-07 | 2016-09-05 | Cisplatin + Docetaxel +Fluorouracil | Y | null | 300017220 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003888 | 300002718 | 1.73 | 81.7 | Curative (C) | 2014-11-05 | 2014-11-21 | CISPLATIN + FLUOROURACIL | N | N | 300017220 | CISPLATIN + FLUOROURACIL |
| 300003889 | 300002719 | 1.55 | 99.5 | Palliative (P) | 2016-09-04 | 2016-09-18 | Cisplatin +Fluorouracil (2 wk) | N | N | 300017222 | CISPLATIN + FLUOROURACIL |
| 300003890 | 300002720 | 1.55 | 66.35 | Neo-adjuvant (N) | 2014-07-23 | 2014-08-01 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300017223 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003891 | 300002721 | 1.61 | null | Adjuvant (A) | 2017-12-08 | 2017-12-29 | Capecitabine | 02 | N | 300017226 | CAPECITABINE |
| 300003892 | 300002722 | 1.66 | 44 | Curative (C) | 2017-12-06 | 2018-01-03 | Cetuximab 7 day (Cycle 1) | 02 | N | 300017227 | CETUXIMAB |
| 300003893 | 300002723 | 1.68 | null | Adjuvant (A) | 2013-07-19 | 2013-08-16 | Capecitabine | N | null | 300017236 | CAPECITABINE |